Stable isotopes from Earth science to bedside medicine: beyond tracers and toward mechanistic biomarkers in medical oncology
Medical Oncology · 2026
DOI: 10.1007/s12032-026-03436-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Oncology, 2026. Verfasst von Emma U Hammarlund und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Development and Evolution (TiDE), Department of Experimental Medical Science, Lund University, Lund, Sweden. emma.hammarlund@med.lu.se. Hauptthemen laut MEDLINE: Isotopes, Medical Oncology, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Swedish Research Council, Swedish Cancer Society.
Abstract (Originalsprache)
Stable isotopes are non-radioactive variants of the same element whose small mass differences produce predictable effects in chemical and biological systems. While medicine has mainly used the administration of enriched stable isotopes as tracers of physiological function, the natural sciences developed stable-isotope ratios into robust measures of source, transformation, and underlying mechanism across Earth and life history. This analytical power – that often goes beyond conventional concentration-based assays – emerged through advances in isotope theory, mass spectrometry, but perhaps most importantly also globally shared reference systematics. Here, we review that trajectory and argue that medicine is positioned for a similar shift, as new computational and analytical tools make isotope analysis increasingly compatible with clinical throughput. In this shift, some natural isotope variation may serve as mechanistic biomarkers of physiology and disease. Integrated with multiomics and machine learning, stable isotopes could support earlier detection, improved risk stratification, and personalized care, particularly in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tissue Development and Evolution (TiDE), Department of Experimental Medical Science, Lund University, Lund, Sweden. emma.hammarlund@med.lu.se.
- Multi-elemental Insights of Origins (MIO) Consortium, Lund, Sweden. emma.hammarlund@med.lu.se.
- Lund University Cancer Center (LUCC), Lund, Sweden. emma.hammarlund@med.lu.se.
- Lund Stem Cell Center (SSC), Lund, Sweden. emma.hammarlund@med.lu.se.
- Globe Institute, University of Copenhagen, Copenhagen, Denmark. emma.hammarlund@med.lu.se.
- Multi-elemental Insights of Origins (MIO) Consortium, Lund, Sweden.
Förderung
- NCI NIH HHS
- Swedish Research Council
- Swedish Cancer Society
- Prostate Cancer Foundation
- Sjöbergstiftelsen
- National Cancer Institute
Zitieren
APA
Hammarlund, E. U., Malmberg, P., Kazi, J. U., Posth, N. R., & Pienta, K. J. (2026). Stable isotopes from Earth science to bedside medicine: beyond tracers and toward mechanistic biomarkers in medical oncology. Medical Oncology. https://doi.org/10.1007/s12032-026-03436-x
Vancouver
Hammarlund EU, Malmberg P, Kazi JU, Posth NR, Pienta KJ. Stable isotopes from Earth science to bedside medicine: beyond tracers and toward mechanistic biomarkers in medical oncology. Medical Oncology. 2026. doi:10.1007/s12032-026-03436-x
BibTeX
@article{Hammarlund2026,
author = {Hammarlund, Emma U and Malmberg, Per and Kazi, Julhash U and Posth, Nicole R and Pienta, Kenneth J},
title = {Stable isotopes from Earth science to bedside medicine: beyond tracers and toward mechanistic biomarkers in medical oncology},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-026-03436-x}
}
EUVIMED